These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12488480)

  • 1. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.
    Spänkuch-Schmitt B; Bereiter-Hahn J; Kaufmann M; Strebhardt K
    J Natl Cancer Inst; 2002 Dec; 94(24):1863-77. PubMed ID: 12488480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.
    Spänkuch B; Matthess Y; Knecht R; Zimmer B; Kaufmann M; Strebhardt K
    J Natl Cancer Inst; 2004 Jun; 96(11):862-72. PubMed ID: 15173270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
    Zhou Q; Bai M; Su Y
    Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.
    Zhou Q; Bai M; Su Y
    Chin Med J (Engl); 2004 Nov; 117(11):1642-9. PubMed ID: 15569479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
    Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
    Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.
    Lane HA; Nigg EA
    J Cell Biol; 1996 Dec; 135(6 Pt 2):1701-13. PubMed ID: 8991084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
    Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
    Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S; Ahmad N
    FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
    Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis.
    van Vugt MA; van de Weerdt BC; Vader G; Janssen H; Calafat J; Klompmaker R; Wolthuis RM; Medema RH
    J Biol Chem; 2004 Aug; 279(35):36841-54. PubMed ID: 15210710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
    Bu Y; Yang Z; Li Q; Song F
    Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
    Hu K; Law JH; Fotovati A; Dunn SE
    Breast Cancer Res; 2012 Feb; 14(1):R22. PubMed ID: 22309939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction with polo-like kinase-1 antisense phosphorothioate oligodeoxynucleotide of colon cancer cell line SW480.
    Fan Y; Zheng S; Xu ZF; Ding JY
    World J Gastroenterol; 2005 Aug; 11(29):4596-9. PubMed ID: 16052696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
    Spänkuch B; Heim S; Kurunci-Csacsko E; Lindenau C; Yuan J; Kaufmann M; Strebhardt K
    Cancer Res; 2006 Jun; 66(11):5836-46. PubMed ID: 16740723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation.
    Meng L; Park JE; Kim TS; Lee EH; Park SY; Zhou M; Bang JK; Lee KS
    Mol Cell Biol; 2015 Aug; 35(15):2626-40. PubMed ID: 26012549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antisense RNA targeting Polo-like kinase 1 on cell growth in A549 lung cancer cells.
    Zhou Q; Su Y; Bai M
    J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):22-6. PubMed ID: 18278450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.
    Golsteyn RM; Mundt KE; Fry AM; Nigg EA
    J Cell Biol; 1995 Jun; 129(6):1617-28. PubMed ID: 7790358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function.
    Cogswell JP; Brown CE; Bisi JE; Neill SD
    Cell Growth Differ; 2000 Dec; 11(12):615-23. PubMed ID: 11149596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
    Liu L; Zhang M; Zou P; Tian L; Liu F
    Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of Polo-like kinase 1 depletion on mitosis and apoptosis of gastric cancer cells.
    Chen XH; Lan B; Qu Y; Zhang XQ; Cai Q; Liu BY; Zhu ZG
    World J Gastroenterol; 2006 Jan; 12(1):29-35. PubMed ID: 16440413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.